Activin A concentrations in human cerebrospinal fluid are age-dependent and elevated in meningitis

Journal of the Neurological Sciences

Volumn 250, Issue 1-2, 2006, Pages 50-57

  Ebert, Sandra ^a   Phillips, David J ^b   Jenzewski, Peter ^a   Nau, Roland ^a   O'Connor, Anne E ^b   Michel, Uwe ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Activin; Cerebrospinal fluid; CNS; Follistatin; Meningitis; Neurological diseases

Indexed keywords

ACTIVIN A; BRAIN PROTEIN; FOLLISTATIN;

ADULT; AGED; ARTICLE; BACTERIUM DETECTION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN TUMOR; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; FEMALE; GROUPS BY AGE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEIZURE; VALIDITY;

ACTIVINS; ADULT; AGED; AGING; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID PROTEINS; ENCEPHALITIS; FEMALE; FOLLISTATIN; HUMANS; IMMUNOASSAY; MALE; MENINGITIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; UP-REGULATION;

EID: 33750512122     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.06.026     Document Type: Article

References (52)

1. Kingsley D.M. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8 (1994) 133-146
2. Ling N., Ying S.-Y., Ueno N., Shimasaki S., Esch F., Hotta M., et al. Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin. Nature 321 (1986) 779-782
3. Vale W., Rivier J., Vaughan J., McClintock R., Corrigan A., Woo W., et al. Purification and characterization of an FSH releasing protein from porcine follicular fluid. Nature 321 (1986) 776-779
4. Woodruff T.K. Regulation of cellular and system function by activin. Biochem Pharmacol 55 (1998) 953-963
5. Phillips D.J. The activin/inhibin family. In: Thomson A., and Lotze M.T. (Eds). The cytokine handbook. edn 4th vol. 2 (2003), Academic Press, London 1153-1177
6. Nakamura T., Takio K., Eto Y., Shibai H., Titani K., and Sugino H. Activin-binding protein from rat ovary is follistatin. Science 247 (1990) 836-838
7. de Winter J.P., ten Dijke P., de Vries C.J.M., van Achterberg T.A.E., Sugino H., de Waele P., et al. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol Cell Endocrinol 116 (1996) 105-114
8. Hashimoto O., Nakamura T., Shoji H., Shimasaki S., Hayashi Y., and Sugino H. A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate. J Biol Chem 272 (1997) 13835-13842
9. Meunier H., Rivier C., Evans R.M., and Vale W. Gonadal and extragonadal expression of inhibin α, βA, and βB subunits in various tissues predicts diverse functions. Proc Natl Acad Sci U S A 85 (1988) 247-251
10. Michel U., Albiston A., and Findlay J.K. Rat follistatin: gonadal and extragonadal expression and evidence for alternative splicing. Biochem Biophys Res Commun 173 (1990) 401-407
11. Kogawa K., Ogawa K., Hayashi Y., Nakamura T., Titani K., and Sugino H. Immunohistochemical localization of follistatin in rat tissues. Endocrinol Jpn 38 (1991) 383-391
12. Tuuri T., Erämaa M., Hildén K., and Ritvos O. The tissue distribution of activin βA- and βB-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J Clin Endocrinol Metab 78 (1994) 1521-1524
13. Wada M., Shintani Y., Kosaka M., Sano T., Hizawa K., and Saito S. Immunohistochemical localization of activin A and follistatin in human tissues. Endocr J 43 (1996) 375-385
14. Schneider O., Nau R., and Michel U. Comparative analysis of follistatin-, activin beta A- and activin beta B-mRNA steady-state levels in diverse porcine tissues by multiplex S1 nuclease analysis. Eur J Endocrinol 142 (2000) 537-544
15. MacConell L.A., Barth S., and Roberts V.J. Distribution of follistatin messenger ribonucleic acid in the rat brain: implications for a role in the regulation of central reproductive functions. Endocrinology 137 (1996) 2150-2158
16. Michel U., Schneider O., Kirchhof C., Meisel S., Smirnov A., Wiltfang J., et al. Production of follistatin in porcine endothelial cells: differential regulation by bacterial compounds and the synthetic glucocorticoid RU 28362. Endocrinology 137 (1996) 4925-4934
17. Roberts V.J., Barth S.L., Meunier H., and Vale W. Hybridization histochemical and immunohistochemical localization of inhibin/activin subunits and messenger ribonucleic acids in the rat brain. J Comp Neurol 364 (1996) 473-493
18. Harada K., Shintani Y., Sakamoto Y., Wakatsuki M., Shitsukawa K., and Saito S. Serum immunoreactive activin A levels in normal subjects and patients with various diseases. J Clin Endocrinol Metab 81 (1996) 2125-2130
19. Wakatsuki M., Shintani Y., Abe M., Liu Z.-H., Shitsukawa K., and Saito S. Immunoradiometric assay for follistatin: serum immunoreactive follistatin levels in normal adults and pregnant women. J Clin Endocrinol Metab 81 (1996) 630-634
20. Loria P., Petraglia F., Concari M., Bertolotti M., Martella P., Luisi S., et al. Influence of age and sex on serum concentrations of total dimeric activin A. Eur J Endocrinol 139 (1998) 487-492
21. Muttukrishna S., Fowler P.A., George L., Groome N.P., and Knight P.G. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J Clin Endocrinol Metab 81 (1996) 3328-3334
22. Sakamoto Y., Shintani Y., Harada K., Abe M., Shitsukawa K., and Saito S. Determination of free follistatin levels in sera of normal subjects and patients with various diseases. Eur J Endocrinol 135 (1996) 345-351
23. Smith C., Yndestad A., Halvorsen B., Ueland T., Wæhre T., Otterdal K., et al. Potential anti-inflammatory role of activin A in acute coronary syndromes. J Am Coll Cardiol 44 (2004) 369-375
24. Yndestad A., Ueland T., Oie E., Florholmen G., Halvorsen B., Attramadal H., et al. Elevated levels of activin A in heart failure. Potential role in myocardial remodeling. Circulation 109 (2004) 1379-1385
25. Michel U., Shintani Y., and Nau R. Serum follistatin concentrations are increased in patients with septicaemia. Clin Endocrinol 48 (1998) 413-417
26. Michel U., Ebert S., Phillips D., and Nau R. Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia. Eur J Endocrinol 148 (2003) 559-564
27. Michel U., Ebert S., Schneider O., Shintani Y., Bunkowski S., Smirnov A., et al. Follistatin (FS) in human cerebrospinal fluid and regulation of FS expression in a mouse model of meningitis. Eur J Endocrinol 143 (2000) 809-816
28. Michel U., Gerber J., O'Connor A.E., Bunkowski S., Brück W., Nau R., et al. Increased activin levels in cerebrospinal fluid of rabbits with bacterial meningitis are associated with activation of microglia. J Neurochem 86 (2003) 238-245
29. Schubert D., Kimura H., LaCorbiere M., Vaughan J., Karr D., and Fischer W.H. Activin is a nerve cell survival molecule. Nature 344 (1990) 868-870
30. Lai M., Gluckman P., Dragunow M., and Hughes P.E. Focal brain injury increases activin βA mRNA expression in hippocampal neurons. Neuroreport 8 (1997) 2691-2694
31. Tretter Y.P., Hertel M., Munz B., ten Bruggencate G., Werner S., and Alzheimer C. Induction of activin A is essential for the neuroprotective action of basic fibroblast growth factor in vivo. Nat Med 6 (2000) 812-815
32. + toxicity. EMBO J 14 (1995) 736-742
33. Iwahori Y., Saito H., Torii K., and Nishiyama N. Activin exerts a neurotrophic effect on cultured hippocampal neurons. Brain Res 760 (1997) 52-58
34. Hughes P.E., Alexi T., Williams C.E., Clark R.G., and Gluckman P.D. Administration of recombinant human activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease. Neuroscience 92 (1999) 197-209
35. Wu D.D., Lai M., Hughes P.E., Sirimanne E., Gluckman P.D., and Williams C.E. Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat. Brain Res 835 (1999) 369-378
36. Florio P., Luisi S., Bruschettini M., Grutzfeld D., Dobrzanska A., Bruschettini P., et al. Cerebrospinal fluid activin A measurement in asphyxiated full-term newborns predicts hypoxic ischemic encephalopathy. Clin Chem 50 (2004) 2386-2389
37. Foster J.A., Puchowicz M.J., McIntyre D.C., and Herkenham M. Activin mRNA induced during amygdala kindling shows a spatiotemporal progression that tracks the spread of seizures. J Comp Neurol 476 (2004) 91-102
38. Knight P.G., Muttukrishna S., and Groome N.P. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. J Endocrinol 148 (1996) 267-279
39. O'Connor A.E., McFarlane J.R., Hayward S., Yohkaichiya T., Groome N.P., and de Kretser D.M. Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study. Hum Reprod 14 (1999) 827-832
40. Evans L.W., Muttukrishna S., and Groome N.P. Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin. J Endocrinol 156 (1998) 275-282
41. Craner M.J., Damarjian T.G., Liu S., Hains B.C., Lo A.C., Black J.A., et al. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. Glia 49 (2004) 220-229
42. 11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15 (2004) 601-609
43. Ouchi Y., Yoshikawa E., Sekine Y., Futatsubachi M., Kanno T., Ogusu T., et al. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol 57 (2005) 168-175
44. Van Everbroeck B., Dobbeleir I., De Waele M., De Leenheir E., Lübke U., Martin J.-J., et al. Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt-Jakob and Alzheimer's disease. Acta Neuropathol 108 (2004) 194-200
45. 11C](R)-PK11195 PET study. Neuroimage 24 (2005) 591-595
46. Borges K., Gearing M., McDermott D.L., Smith A.B., Almonte A.G., Wainer B.H., et al. Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp Neurol 182 (2003) 21-34
47. Rosell D.R., Nacher J., Akama K.T., and McEwen B.S. Spatiotemporal distribution of gp130 cytokines and their receptors after status epilepticus: comparison with neuronal degeneration and microglial activation. Neuroscience 122 (2003) 329-348
48. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr Opin Neurol 18 (2005) 315-321
49. Lai M., Sirimanne E., Williams C.E., and Gluckman P.D. Sequential patterns of inhibin subunit gene expression following hypoxic-ischemic injury in the rat brain. Neuroscience 70 (1996) 1013-1024
50. McCarthy S.A., and Bicknell R. Inhibition of vascular endothelial cell growth by activin-A. J Biol Chem 268 (1993) 23066-23071
51. Mylonas I., Jeschke U., Shabani N., Kuhn C., Friese K., and Gerber B. Inhibin/activin subunits (inhibin-α, -βA and -βB) are differentially expressed in human breast cancer and their metastasis. Oncol Rep 13 (2005) 81-88
52. Andreasson K., and Worley P.F. Induction of β-A activin expression by synaptic activity and during neocortical development. Neuroscience 69 (1995) 781-796